Atenolol
Inquiry
| Post Date: | Jan 09,2018 |
| Expiry Date: | Jul 08,2018 |
| Detailed Description: |
Cas No. :29122-68-7
Quantity: mass in stockKilograms Specs:white powder Price:negotiable USD Kilograms Payment Method: T/T, Western Union,Moneygram and Bitcoin. Description: Atenolol is a selective β1 receptor antagonist, a drug belonging to the group of beta blockers (sometimes written β-blockers), a class of drugs used primarily in cardiovascular diseases. Introduced in 1976, atenolol was developed as a replacement for propranolol in the treatment of hypertension. It works by slowing down the heart and reducing its workload. Unlike propranolol, atenolol does not readily pass through the blood–brain barrier, thus decreasing the incidence of central nervous system side effects. Atenolol is one of the most widely used β-blockers in the United Kingdom and was once the first-line treatment for hypertension. Atenolol is effective at reducing blood pressure, but recent studies indicate that it does not reduce the morbidity or mortality caused by hypertension, and may even increase mortality in some subgroups. This means that when people take this drug, they get better blood pressure numbers, but they still die of heart attacks and strokes, despite the lower blood pressure. In addition, the role for β-blockers in general in hypertension was downgraded in June 2006 in the United Kingdom, and later in the United States, as they are less appropriate than newer blood pressure medications including calcium channel blockers, thiazide diuretics, angiotension converting enzyme (ACE) inhibitors, and angiotension receptor blockers, particularly in the elderly. Medical uses Atenolol is used for a number of conditions including hypertension, angina, long QT syndrome, acute myocardial infarction, supraventricular tachycardia, ventricular tachycardia, and the symptoms of alcohol withdrawal. Off-label uses of atenolol, as with other cardioselective β-blockers, include symptomatic treatment of psychological issues such as anxiety. β-blockers are effective for some in treating the somatic (physical) effects of anxiety. In these instances, dosing is used as needed instead of regular daily dosing. Due to its hydrophilic (water-attracting) properties, the drug is less suitable in migraine prophylaxis compared to propranolol, because, for this indication, atenolol would have to reach the brain in high concentrations, which is not the case, because atenolol does not pass through the blood–brain barrier. |
| CAS Registry Number: | 29122-68-7 |
| Synonyms: | ;2-[4-(2-hydroxy-3-isopropylaminopropoxy)phenyl]acetamide;2-(4-{[(2S)-2-hydroxy-3-(propan-2-ylamino)propyl]oxy}phenyl)acetamide;(2R)-3-[4-(2-amino-2-oxoethyl)phenoxy]-2-hydroxy-N-(1-methylethyl)propan-1-aminium;(2S)-3-[4-(2-amino-2-oxoethyl)phenoxy]-2-hydroxy-N-(1-methylethyl)propan-1-aminium;()-2-[4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]acetamide;(+-)-4-(2-Hydroxy-3-isopropylaminopropoxy)phenylacetamide;(+-)-Atenolol;(1)-2-(4-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide;Benzeneacetamide, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, (+-)-; |
| Molecular Formula: | C14H22N2O3 |
| Molecular Weight: | 266.3435 |
| Molecular Structure: | 
|
| Company: | Hengyang Desen Biotechnology Co., Ltd. [ China ] |
| Contact: | ava |
| Tel: | 86-18908446905 |
| Fax: | |
| Email: | ava@ycgmp.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
